Publications by authors named "Tahsin Ozatli"

Claim this Profile
C
Comprehensive Evaluation of a 1021-Gene Panel in FFPE and Liquid Biopsy for Analytical and Clinical Use.
Angeliki Meintani, Mustafa Ozdogan, Nikolaos Touroutoglou, Konstantinos Papazisis, Ioannis Boukovinas, Tahsin Ozatli

Int J Mol Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing.
Konstantinos Agiannitopoulos, Georgia Pepe, Georgios N Tsaousis, Kevisa Potska, Dimitra Bouzarelou, Tahsin Ozatli

Cancer Genomics Proteomics· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive tumor molecular profile analysis in clinical practice.
Mustafa Özdoğan, Eirini Papadopoulou, Nikolaos Tsoulos, Aikaterini Tsantikidi, Vasiliki-Metaxa Mariatou

BMC Med Genomics· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Objective response rate assessment in oncology: Current situation and future expectations.
Nuri Faruk Aykan, Tahsin Özatlı

World J Clin Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential therapy and prognostic factors in metastatic renal cell carcinoma: single centre experience.
Onur Esbah, Umut Demirci, Kaan Helvaci, Fatma Paksoy Turkoz, Ahmet Siyar Ekinci, Tahsin Ozatli

J BUON· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas.
İrfan Cicin, Tahsin Özatlı, Esma Türkmen, Türkan Özturk, Melike Özçelik

Balkan Med J· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma.
Ahmet Siyar Ekinci, Umut Demirci, Berna Cakmak Oksuzoglu, Ayse Ozturk, Onur Esbah, Tahsin Ozatli

J BUON· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and prognostic factors in primary peritoneal carcinoma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO).
Olcun U Unal, Ilhan Oztop, Ozan Yazici, Tahsin Ozatli, Ali Inal

Oncol Res Treat· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the Anatolian Society of Medical Oncology (ASMO).
Olcun Umit Unal, Ilhan Oztop, Nurgul Yasar, Zuhat Urakci, Tahsin Ozatli

Thorac Cancer· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen.
Mehmet Ali Nahit Sendur, Nuriye Ozdemir, Tahsin Özatlı, Ozan Yazıcı, Sercan Aksoy

Med Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastric carcinoma with bone marrow metastasis: a case series.
Ahmet Şiyar Ekinci, Oznur Bal, Tahsin Ozatlı, Ibrahim Türker, Onur Eşbah

J Gastric Cancer· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis